http://www.unboundmedicine.com/medline/ebm/research/efalizumabUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19917976/full_citation/Linking_publication_about_efalizumab_effectiveness_with_safety_concerns_Robinson JK 
Linking publication about efalizumab effectiveness with safety concerns. [Comment, Letter]
Arch Dermatol 2009 Nov; 145(11):1338.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19916298/full_citation/The_status_of_biologic_therapies_in_the_treatment_of_moderate_to_severe_psoriasis_Menter A 
The status of biologic therapies in the treatment of moderate to severe psoriasis. [Journal Article, Research Support, Non-U.S. Gov't]
Cutis 2009 Oct; 84(4 Suppl):14-24.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19912461/full_citation/Evidence_based__S3__guideline_for_the_treatment_of_psoriasis_vulgaris___Update:_"Therapeutic_options"_and_"Efalizumab"Nast A, Augustin M, Boehncke WH, et al. 
Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab" [JOURNAL ARTICLE]
J Dtsch Dermatol Ges 2009 Nov 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19804692/full_citation/Sunitinib_for_the_treatment_of_gastrointestinal_stromal_tumours:_a_critique_of_the_submission_from_Pfizer_Bond M, Hoyle M, Moxham T, et al. 
Sunitinib for the treatment of gastrointestinal stromal tumours: a critique of the submission from Pfizer. [Journal Article, Research Support, Non-U.S. Gov't]
Health Technol Assess 2009 Sep.:69-74.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19804689/full_citation/Adalimumab_for_the_treatment_of_psoriasis_Turner D, Picot J, Cooper K, et al. 
Adalimumab for the treatment of psoriasis. [Journal Article, Research Support, Non-U.S. Gov't]
Health Technol Assess 2009 Sep.:49-54.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19907722/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19889301/full_citation/Efficiency_of_Biologic_Agents_in_the_Treatment_of_Moderate_to_Severe_Psoriasis_Blasco AJ, Lázaro P, Ferrándiz C, et al. 
Efficiency of Biologic Agents in the Treatment of Moderate to Severe Psoriasis. [JOURNAL ARTICLE]
Actas Dermosifiliogr 2009 Nov; 100(9):792-803.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19880554/full_citation/Efalizumab_for_subacute_cutaneous_lupus:_report_of_two_different_outcomes_Sánchez-Cano D, Callejas-Rubio JL, Ríos-Fernández R, et al. 
Efalizumab for subacute cutaneous lupus: report of two different outcomes. [JOURNAL ARTICLE]
Lupus 2009 Oct 30.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19874434/full_citation/Retrospective_analysis_of_systemic_treatments_for_psoriasis_patients_attending_a_Psocare_center_in_Florence__Relevance_of_biological_drugs_use_and_comorbidities_Prignano F, Pescitelli L, Ricceri F, et al. 
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. [JOURNAL ARTICLE]
J Eur Acad Dermatol Venereol 2009 Oct 23.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19845720/full_citation/Long_term_efficacy_of_biologics_in_the_treatment_of_psoriasis:_what_do_we_really_knowAlwawi EA, Krulig E, Gordon KB 
Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? [Journal Article]
Dermatol Ther 2009 Sep-Oct; 22(5):431-40.
Abstract | Full Citation | Find Related Articles